Ep 32 | Getting to Know the HRSA DRL: Part 1 – Policies & Procedures
340B Unscripted6 Marras 2023

Ep 32 | Getting to Know the HRSA DRL: Part 1 – Policies & Procedures

This episode is the first part of a series of recordings we are putting together to review the HRSA data request list (DRL). Rob and Greg discuss DRL item #1 – 340B Policies and Procedures. They’ll review the types of operations that HRSA expects to see outlined in a covered entity’s 340B policies and share some insights into how to manage these documents.

HRSA audit readiness and a detailed overview of the DRL will be the subject of our next SpendMend Pharmacy Webinar in December 2023. Look for more information on registering for this webinar on our social media pages.

Have a suggested podcast topic? Email us at 340BUnscripted@spendmend.com with your ideas.

Jaksot(91)

Ep 45 | Chevron Doctrine & 340B

Ep 45 | Chevron Doctrine & 340B

In this episode, Greg and Rob are joined by healthcare attorney Ross Marguiles to discuss how a Supreme Court ruling on litigation in the fishing industry could have a major impact on the healthcare l...

22 Touko 202454min

Ep 44 | Pharmacotherapy Clinic Services & 340B

Ep 44 | Pharmacotherapy Clinic Services & 340B

In this episode, SpendMend colleague Matt Parker joins Greg and Rob (14:00) to discuss pharmacotherapy services, and how pharmacist-driven care can help promote improved health outcomes in a community...

6 Touko 202453min

Ep 43 | Getting to Know the HRSA DRL – DRL 8 Self-Disclosure Documentation and DRL 9 Medicaid Billing Information

Ep 43 | Getting to Know the HRSA DRL – DRL 8 Self-Disclosure Documentation and DRL 9 Medicaid Billing Information

In this episode, Greg and Rob continue to provide insights on the HRSA data request list.   DRL #8 is self-disclosure documentation and DRL #9 is Medicaid billing information, which includes providing...

22 Huhti 202451min

Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 2

Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 2

SpendMend colleagues Jasmine and Megan continue their conversation providing some grantee CE perspectives concerning the HRSA DRL.

15 Huhti 202444min

Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1

Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1

In this episode, SpendMend colleagues Jasmine and Megan provide some grantee CE perspectives concerning the HRSA DRL.  They have so much great insight, we are breaking this conversation up into two pa...

8 Huhti 202448min

Ep 41 | 340B News & Notes

Ep 41 | 340B News & Notes

In this episode, Rob and Greg catch up on a cluster of developments in the 340B space, including updates to manufacturer contract pharmacy restrictions, thoughts on a federal appellate court ruling on...

25 Maalis 202429min

Ep 40 | Getting to Know the HRSA DRL: DRL 5 Purchasing Documentation and DRL 7 Entity-Owned Pharmacy Documentation

Ep 40 | Getting to Know the HRSA DRL: DRL 5 Purchasing Documentation and DRL 7 Entity-Owned Pharmacy Documentation

In this episode, Greg and Rob continue reviewing data solicited by HRSA during an audit. DRL #5 is purchasing documentation, including a list of accounts, sample invoices, and 340B purchase order deta...

11 Maalis 202448min

Ep 39 | A Revisit of Ongoing Contract Pharmacy Restrictions

Ep 39 | A Revisit of Ongoing Contract Pharmacy Restrictions

In this episode, Greg and Rob are once again joined by SpendMend team member Riley Protz, to catch up on the current state of ongoing manufacturer restrictions on 340B contract pharmacy operations, as...

26 Helmi 202432min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
rss-lahtijat
rss-draivi
rss-porssipuhetta
rahapuhetta
oppimisen-psykologia
rss-rahamania
rss-seuraava-potilas
rss-neuvottelija-sami-miettinen
rss-bisnesta-bebeja
rss-paatos-podcast-suomen-kovimmat-paatoksentekijat-2
rss-paasipodi
rss-40-ajatusta-aanesta
taloudellinen-mielenrauha
syo-nuku-saasta
kasvun-kipuja
rss-viisas-raha-podi